Volume 17, Number 3—March 2011
Dispatch
Livestock-associated Methicillin-Resistant Staphylococcus aureus in Humans, Europe
Table 1
Laboratory no. | Country | Type of laboratory | Source of MRSA isolates | No. MRSA isolates received | No. MRSA isolates typed | MRSA ST398 isolates |
|
---|---|---|---|---|---|---|---|
No. (%) | 95% CI | ||||||
1 | Austria | National ref | All | 523 | 523 | 0 | 0–0.7 |
2 | Austria | National ref | All | 586 | 586 | 16 (2.7) | 1.7–4.4 |
3 | Belgium | National ref | All | 329 | 149 | 7 (4.7) | 2.3–9.4 |
4 | Czech Republic | National ref | Blood | 37 | 10 | 0 | 0–27.8 |
5 | Denmark | National ref | All | 659 | 659 | 14 (2.1) | 1.3–3.5 |
Denmark | National ref | Clinical | 370 | 370 | 6 (1.6) | 0.7–3.5 | |
6 | Finland | National ref | All | 1,323 | 1,323 | 1 (0.1) | 0–0.4 |
7 | Germany | National ref | Clinical | 1,293 | 1,293 | 9 (0.7) | 0.4–1.3 |
8 | Germany | Regional ref | Clinical | 866 | 866 | 37 (4.3) | 3.1–5.8 |
9 | Greece | National ref | Clinical | 336 | 336 | 0 | 0–1.1 |
10 | Hungary | National ref | All | 365 | 63 | 0† | NA |
11 | Iceland | National ref | Clinical | 21 | 21 | 0 | 0–15.5 |
12 | Italy | National ref | Clinical | 108 | 108 | 1 (0.9) | 0.2–5.1 |
13 | Ireland | National ref | Clinical | 832 | 696 | 0 | 0–0.5 |
14 | The Netherlands | National ref | Clinical | 478 | 478 | 57 (11.9) | 9.3–15.1 |
15 | The Netherlands | Local | Clinical | 12 | 12 | 3 (25.0) | 8.9–53.2 |
16 | Sweden | National ref | All | 1,127 | 1,127 | 8 (0.7) | 0.4–1.4 |
17 | Switzerland | Local | Clinical | 587 | 65 | 0† | NA |
18 | Switzerland | Regional ref | All | 182 | 182 | 0 | 0–2.1 |
19 | Switzerland | Regional ref | Clinical | 64 | 64 | 0 | 0–5.7 |
20 | Switzerland | Local | All | 80 | 78 | 0 | 0–4.7 |
21 | Turkey | Local | Clinical | 198 | 60 | 0 | 0–6.0 |
*MRSA, methicillin-resistant Staphylococcus aureus; ST398, sequence type 398; CI, confidence interval; ref, reference laboratory; NA, not applicable.
†Not reported because laboratory typed <25% of MRSA isolates.
1Current affiliation: European Centre for Disease Prevention and Control, Stockholm, Sweden.
Page created: July 25, 2011
Page updated: July 25, 2011
Page reviewed: July 25, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.